PP2A-B56-δ Activators

PP2A-B56-δ Activators are a group of chemicals that indirectly influence the activity of PP2A-B56-δ, a regulatory subunit of the PP2A complex, through modulation of the PP2A complex itself or associated signaling pathways. This set of activators, while not directly targeting PP2A-B56-δ, provides insights into its regulatory mechanisms within the broader context of cellular signaling and function. FTY720 (Fingolimod), for example, is phosphorylated in vivo to form FTY720-P, activating PP2A and potentially influencing PP2A-B56-δ activity as part of the larger complex. Okadaic Acid and Calyculin A, potent inhibitors of PP2A, are instrumental in studying PP2A regulation and function, indirectly contributing to the understanding of PP2A-B56-δ's role.

Other compounds like LB-100, Cantharidin, and Endothall, which inhibit PP2A, offer a window into the regulatory mechanisms and functions of PP2A complexes, including PP2A-B56-δ. Forskolin, known for increasing cAMP levels, indirectly influences PP2A-B56-δ by modulating cellular signaling pathways that interact with the PP2A complex. Bioactive lipids like Sphingosine and synthetic analogs like C2-ceramide affect PP2A-B56-δ indirectly through their influence on PP2A complex activity. Microcystin-LR and Tautomycetin, as cyanobacterial and bacterial toxins respectively, provide research tools to understand PP2A complex regulation, thereby shedding light on PP2A-B56-δ. Finally, compounds like BIM-1, inhibiting protein kinases, can indirectly affect PP2A-B56-δ through modulation of associated cellular signaling pathways